Be part of the knowledge.™

Global Oncology Academy

The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.

For more information about GOA, visit www.globaloncologyacademy.org.

877

LikeLikedUnlike

1-15 of 422

Evidence-Based Care for PD-L1-Negative Non-Small Cell Lung Cancer
Project Oncology®
Evidence-Based Care for PD-L1-Negative Non-Small Cell Lung Cancer
- Steve Jackson, PharmD
- Apar Kishor Ganti, MD
- Thomas Marron, MD, PhD
Factors Guiding First-Line Treatment Decisions for Myelofibrosis and Anemia
Project Oncology®
Factors Guiding First-Line Treatment Decisions for Myelofibrosis and Anemia
- Charles Turck, PharmD, BCPS, BCCCP
- Douglas A. Tremblay, MD
Menin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice
CME/CE
Menin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice
- Amer Zeidan, MBBS
- Ghayas Issa, MD
0.50 credits
CME/CE Virtual Event
Targeting TROP2 in EGFR-Mutated Advanced NSCLC: Navigating the ADC Revolution After TKI Failure
Multiple dates available
0.50 credits
Case Consult: Treatment Strategies for HER2-Positive Platinum-Resistant Ovarian Cancer
MinuteCE®
Case Consult: Treatment Strategies for HER2-Positive Platinum-Resistant Ovarian Cancer
- Kathleen N. Moore, MD
- Ritu Salani, MD
1.00 program credits
Case Consult: Targeting CDH6 in Platinum-Resistant Ovarian Cancer
MinuteCE®
Case Consult: Targeting CDH6 in Platinum-Resistant Ovarian Cancer
- Kathleen N. Moore, MD
- Ritu Salani, MD
1.00 program credits
advertisement
Case Consult: Treatment Strategies for FRα-Positive Platinum-Resistant Ovarian Cancer
MinuteCE®
Case Consult: Treatment Strategies for FRα-Positive Platinum-Resistant Ovarian Cancer
- Kathleen N. Moore, MD
- Ritu Salani, MD
1.00 program credits
Case Consult: Personalizing First-Line Maintenance Therapy in Advanced Ovarian Cancer
MinuteCE®
Case Consult: Personalizing First-Line Maintenance Therapy in Advanced Ovarian Cancer
- Kathleen N. Moore, MD
- Ritu Salani, MD
1.00 program credits
Axatilimab’s Impact on cGVHD and Associated BOS
Project Oncology®
Axatilimab’s Impact on cGVHD and Associated BOS
- Charles Turck, PharmD, BCPS, BCCCP
- Amandeep Salhotra, MD
Real-World Outcomes with Axatilimab in cGVHD
Project Oncology®
Real-World Outcomes with Axatilimab in cGVHD
- Brian P. McDonough, MD, FAAFP
- Hana Safah, MD
CME/CE Virtual Event
Closing the Gap in First-Line Treatment of KRAS G12C–Mutated Advanced NSCLC: From Biology to Bedside Decisions and Trial-Ready Care
Multiple dates available
0.75 credits
The Art of Treatment Sequencing in Advanced Urothelial Carcinoma
Project Oncology®
The Art of Treatment Sequencing in Advanced Urothelial Carcinoma
- Guru P. Sonpavde, MD
advertisement
Advanced Urothelial Carcinoma: Optimizing Second-Line Care
Project Oncology®
Advanced Urothelial Carcinoma: Optimizing Second-Line Care
- Guru P. Sonpavde, MD
Current Approaches to Advanced Urothelial Carcinoma
Project Oncology®
Current Approaches to Advanced Urothelial Carcinoma
- Guru P. Sonpavde, MD
First-Line Treatment Considerations in Advanced Urothelial Carcinoma
Project Oncology®
First-Line Treatment Considerations in Advanced Urothelial Carcinoma
- Guru P. Sonpavde, MD

Program Chapters

Segment Chapters

Playlist:

Recommended